Dr. Suhail Qureshi

Dr. Suhail Qureshi is an Additional Director & Unit Head – Medical Oncology at Fortis Hospital, Shalimar Bagh, New Delhi, with over 14 years of experience in the diagnosis and treatment of a wide spectrum of cancers. He is committed to providing evidence-based, patient-centric cancer care through a multidisciplinary approach, combining advanced therapies with personalized treatment plans to achieve the best possible outcomes. He completed his MBBS from Bharati Vidyapeeth Medical College, Pune, followed by DNB in General Medicine from Safdarjung Hospital & Vardhman Mahavir Medical College, New Delhi. He further pursued a Fellowship in Medical Oncology, Hematology & Bone Marrow Transplantation at Medanta – The Medicity, Gurugram, and obtained his DNB in Medical Oncology from BLK Super Speciality Hospital, New Delhi. Dr. Qureshi has expertise in the management of breast cancer, lung cancer, gastrointestinal cancers, head & neck cancers, gynecological cancers, genitourinary cancers, thoracic malignancies, sarcomas, melanoma, and hematological malignancies. His clinical interests include chemotherapy, immunotherapy, targeted therapy, hormonal therapy, precision oncology, molecular-guided treatment, and supportive cancer care. An active academician, Dr. Qureshi has contributed to several national and international research publications and has presented scientific papers at leading oncology conferences. He remains actively involved in clinical research and continuing medical education, ensuring his patients benefit from the latest advances in cancer diagnosis and treatment. Known for his compassionate approach and clinical excellence, Dr. Qureshi believes in empowering patients through clear communication, shared decision-making, and comprehensive cancer care throughout their treatment journey.

Poster titled “An interesting case of Lung Mass” presented at 9th SAARC Federation of Oncology Conference held at Gurgaon in Nov 2014 Poster titled “Metachronous occurrence of Multiple Myeloma in Castrate resistant Prostate Cancer” presented at 9th SAARC Federation of Oncology Conference held at Gurgaon in Nov 2014 Kaposi Sarcoma in Non-immunocompromised Adult. Bhasin A, Singal RK, Agarwal A, Qureshi S, Anand G, D C, Sachan S. J Assoc Physicians India. 2018 Sep;66(9):90. PMID: 31321939. Contributed book chapter as co-author on “Chemotherapy, immunotherapy and Endocrine Biology for Gynecologic malignancies and research in Gynecologic Oncology” in “A textbook of Clinical Oncology in the Indian context” by Dr. Suresh Sanchetee (2019) Contributed book chapter as co-author on “Gestational Trophoblastic disease” in “A textbook of Clinical Oncology in the Indian context” by Dr. Suresh Sanchetee (2019) Abstract titled “PARP inhibitor in platinum resistant ovarian cancer: Single center real world experience” presented at ESMO Asia Congress, Singapore, Nov 2019 Original article titled “PARP inhibitor in platinum resistant ovarian ca